CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleRevenue is $641.41M, above the global median of $520.53M
- FinancialsAltman Z-Score -0.97: distress zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
277.87MUSDvs all stocks (USD)
Revenue (TTM)
641.41MUSDvs all stocks (USD)
Profit Margin
-20.90%Beta
1.72xvs all stocks
52-Week Change
21.95%vs all stocks
Market Capitalization
277.87MUSDvs all stocks (USD)
Enterprise Value
740.87MUSDvs all stocks (USD)
Forward P/E
-12.34xPrice to Sales (TTM)
0.4332xPrice to Book (MRQ)
0.8278xEnterprise to Revenue
1.16xEnterprise to EBITDA
6.04xGross Margin
49.86%Profit Margin
-20.90%Operating Margin
7.38%Return on Assets (TTM)
3.64%Return on Equity (TTM)
-45.77%Revenue (TTM)
641.41MUSDvs all stocks (USD)
Revenue per Share (TTM)
1.79USDUpdated Jul 18, 2026Quarterly Revenue Growth
-8.70%Gross Profit (TTM)
321.39MUSDvs all stocks (USD)
EBITDA (TTM)
142.53MUSDvs all stocks (USD)
Net Income (TTM)
-134.05MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
-8.71%Operating Cash Flow (TTM)
36.80MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
-23.94MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Jul 18, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%Minority Interest (Equity)
-87.95MUSDFY2025 · Dec 31, 2025Revenue
655.85MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
331.28MUSDFY2025 · Dec 31, 2025Gross Profit
324.57MUSDFY2025 · Dec 31, 2025Operating Income
76.94MUSDvs all stocks (USD)
Pre-tax Income
-95.42MUSDFY2025 · Dec 31, 2025Income Tax Expense
44.62MUSDFY2025 · Dec 31, 2025Net Income
-140.04MUSDFY2025 · Dec 31, 2025EBIT
-35.39MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
144.90MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
247.45MUSDFY2025 · Dec 31, 2025Non-operating Interest Income
3.75MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
60.03MUSDFY2025 · Dec 31, 2025Net Income from Continuing Operations
-140.04MUSDFY2025 · Dec 31, 2025Minority Interests (P&L)
4.64MUSDFY2025 · Dec 31, 2025Operating Cash Flow
-86.29MUSDFY2025 · Dec 31, 2025Free Cash Flow
-120.75MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
94.33MUSDFY2025 · Dec 31, 2025Income Tax Paid
6.96MUSDFY2025 · Dec 31, 2025Interest Paid
51.34MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-140.04MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
55.74MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
-5.25MUSDFY2025 · Dec 31, 2025Stock-based Compensation
11.23MUSDFY2025 · Dec 31, 2025Other Non-cash Items
-1.16MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
12.04MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
8.62MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-27.46MUSDFY2025 · Dec 31, 2025Capital Expenditures
-34.46MUSDFY2025 · Dec 31, 2025Net Intangibles (CF)
-3.04MUSDFY2025 · Dec 31, 2025Net Acquisitions
-4.91MUSDFY2025 · Dec 31, 2025Other Investing Activity
1.71MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-37.66MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
312.00MUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-371.74MUSDFY2025 · Dec 31, 2025Common Stock Repurchase
0.00USDFY2025 · Dec 31, 2025Other Financing Charges
-22.36MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-82.10MUSDFY2025 · Dec 31, 2025Shares Outstanding
370.50MSharesUpdated Jul 18, 2026Float Shares
345.56MSharesUpdated Jul 18, 2026% Held by Insiders
2.06%vs all stocks
% Held by Institutions
3.51%vs all stocks
Total Cash (MRQ)
32.34MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
0.0870USDUpdated Jul 18, 2026Total Debt (MRQ)
586.78MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
2.40xCurrent Ratio (MRQ)
2.51xBook Value per Share (MRQ)
0.9060USDUpdated Jul 18, 2026Total Assets
1.20BUSDvs all stocks (USD)
Total Current Assets
259.27MUSDFY2025 · Dec 31, 2025Total Liabilities
944.80MUSDFY2025 · Dec 31, 2025Total Non-current Assets
938.03MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
844.62MUSDFY2025 · Dec 31, 2025Total Current Liabilities
100.18MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
57.90MUSDFY2025 · Dec 31, 2025Accounts Receivable
37.89MUSDFY2025 · Dec 31, 2025Inventory
98.67MUSDFY2025 · Dec 31, 2025Accounts Payable
16.54MUSDFY2025 · Dec 31, 2025Short-term Debt
23.06MUSDFY2025 · Dec 31, 2025Deferred Revenue
2.57MUSDFY2025 · Dec 31, 2025Long-term Debt
561.11MUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
72.60MUSDFY2025 · Dec 31, 2025Common Stock (Book)
1.72BUSDFY2025 · Dec 31, 2025Retained Earnings
-1.50BUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
252.50MUSDvs all stocks (USD)
52-Week Low
0.5140USDUpdated Jul 18, 202652-Week High
2.30USDUpdated Jul 18, 202652-Week Change
21.95%vs all stocks
Beta
1.72xvs all stocks
50-Day MA
0.8611USDUpdated Jul 18, 2026200-Day MA
1.03USDUpdated Jul 18, 2026Avg 10-Day Volume
409.44KSharesUpdated Jul 18, 2026Avg 30-Day Volume
509.87KSharesUpdated Jul 18, 2026Diluted EPS (TTM)
-0.3800USDUpdated Jul 18, 2026Other Income / Expense
-116.09MUSDFY2025 · Dec 31, 20251 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Within or Near the Altman Distress Zone
Debt is a large share of its assets, and large against its cash flow.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.50Profit Margin: -0.21
Looks liquid, but the distress score says otherwiseNotable
Current Ratio: 2.51Altman Z-Score: -0.97
Financial Health
Altman Z-Score -0.97: distress zoneCritical
Altman Z-Score: -0.97
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Revenue is $641.41M, above the global median of $520.53MNotable
Revenue (USD): 641,414,976Global Median: 520,528,949.311
Companies that share the same coordination system — how they create, deliver, or capture value.
Alx Oncology Holdings Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Curocell Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Dirui Industrial Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Oryzon Genomics S.A.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Northwest Biotherapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Sab Biotherapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Sichuan Gangtong Medical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Opus Genetics Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
United Orthopedic Corporation
Tier 1ProductionApproval-Gated PipelineRule
Shanghai Hile Bio-Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Ch. Karnchang Public Company Limited
1 interpretationWithin or Near the Altman Distress Zone
Shandong Longda Meishi Co., Ltd.
1 interpretationWithin or Near the Altman Distress Zone
China High-Speed Railway Co., Ltd.
1 interpretationWithin or Near the Altman Distress Zone